The statement you made was from an 8k filed by Radient. Once again, Mac severely BENT the truth.
What Mac said was this:
A new independent scientific study published in the Oncogenesis, Inflammatory and Parasitic Tropical Diseases of the Lung edited by Jean-Marie Kayembe, ISBN 978-953-51-0982-2, published February 13, 2013, indicated that Onko-Sure® itself might contribute to confirm tumor diagnosis and to identify patients with advanced lung cancer, with high sensitivity (95.8%) and specificity (91.9%). This new data strengthens our views that Onko-Sure® can be used as a lung cancer screening tool.
What the article said was this.
"The data shows that DR70 itself might contribute to confirm tumour diagnosis and to
identify patients with advanced LC, with high sensitivity (Table 3). However, the test
would be better identifying negative LC cases with a high specificity and Negative
Predictive Value (NPV)."
What that means is that the false positives are so high, that a negative test result is much more accurate than a positive test.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
